by Scott Martin | Sep 15, 2019 | Weekly Newsletter 7pm Sunday
The Weekly Summary Every so often, investors benefit from a simple gut check. When our stocks are going up, it's nice to verify that the gains are truly justified and there's room for more upside when the market winds blow in the right direction. And when our stocks...
by Scott Martin | Jul 26, 2019 | 7am News Flash
The first heavy week of 2Q19 earnings season has been solid on the whole. Most BMR companies have delivered results somewhere between encouraging and euphoric. We expect this morning's reports will follow the trend. Yesterday, for example, AstraZeneca (AZN: $43, up 6%...
by Todd Shaver | Apr 7, 2016 | 6pm News Flash
AstraZeneca (AZN) is a United Kingdom-based pharmaceutical firm with a solid history of delivering high quality medicines to markets globally. The company’s UK basis is also a competitive advantage in bringing drugs to market in non-FDA regions before coming...
